Olin, Shih-Shin Chang, is a Principal Scientist in Discovery Biologics at Merck, specializing in cancer and immune biology with extensive experience in antibody-related drug development. They have led multidisciplinary teams and portfolio programs, optimizing cell assays and supporting numerous immuno-oncology initiatives. Olin holds a Ph.D. in Cancer Biology from The University of Texas MD Anderson Cancer Center and has published over 32 research papers. Previously, they contributed to notable organizations including Bristol Myers Squibb, where they received a $250K Innovation Grant for their work.
This person is not in the org chart
This person is not in any teams
This person is not in any offices